Clinical Trials Directory

Trials / Unknown

UnknownNCT02290314

Midline Lumbar Fusion Versus Posterior Lumbar Interbody Fusion

Minimal Access Midline Lumbar Fusion Versus Traditional Open Posterior Lumbar Interbody Fusion for Degenerative Lumbar Spondylolisthesis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
The London Spine Centre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Degenerative lumbar spondylolisthesis is the forward displacement (slip) of one vertebra on an adjacent vertebra resulting in narrowing of the spinal canal or compression of the exiting nerve roots. It is commonly associated with low back and leg pain, and is a frequent reason for spine surgery particularly in individuals over age 65 years. Recently novel minimally invasive surgical techniques have heightened public and government interest by touting benefits of reduced approached-related morbidity which in turn leads to quicker recovery, shorter hospital stay, improved short-term clinical outcomes, and reduced health care cost. However, there is no randomized controlled trial evidence to describe the actual advantages and disadvantages associated with minimally invasive spinal fusion. This pilot study is a randomized control trial comparing minimally invasive MID-line Lumbar Fusion (MIDLF) to traditional "open" posterior lumbar interbody fusion (PLIF) with respect to length of stay, approach related morbidity, patient centered outcome measures, and cost-effectiveness in the treatment of degenerative lumbar spondylolisthesis.

Conditions

Interventions

TypeNameDescription
PROCEDUREminimally invasive MID-line Lumbar Fusion (MIDLF)
PROCEDUREPosterior lumbar interbody fusion (PLIF)

Timeline

Start date
2014-12-01
Primary completion
2018-12-01
Completion
2019-12-01
First posted
2014-11-14
Last updated
2018-08-20

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT02290314. Inclusion in this directory is not an endorsement.